Высокодозная химиотерапия и трансплантация аутологичных гемопоэтических стволовых клеток у больных множественной миеломой, протекающей с почечной недостаточностью
О. С. Покровская, Savchenko Vg(National Research Center for Hematology Russian Academy of Medical Sciences), Е С Урнова, И Г Рехтина, И В Гальцева, Larisa A. Kuzmina(Ministry of Health of the Russian Federation), Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Е. Ю. Варламова, И. В. Таусон, М В Нарейко(Endocrinology Research Center), Э. А. Боева, М. В. Фирсова(Ministry of Health of the Russian Federation), Е. Н. Паровичникова(National Research Center for Hematology Russian Academy of Medical Sciences)
Гематология и трансфузиология
January 1, 2014
Cited by 0
Related Papers
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59